NEMA NU 2-2001 performance testing of a Philips Gemini GXL PET/CT scanner

Abstract

Post installation acceptance testing is vital to demonstrate that the equipment meets the vendor's specification and is suitable for clinical studies. The test procedures described in the NEMA NU 2-2001 document form the basis of vendor performance specifications of PET scanners and hence are also appropriate for acceptance testing. Initial installation performance tests of the Philips Gemini GXL PET/CT scanner installed at Liverpool Hospital revealed that the peak noise equivalent count rate (NECR) measurement of 57.5 kcps was substantially lower than the specification of 70 kcps and the scatter fraction of 38.5% was 10% higher than the specification of <or=35%. These performance parameters potentially impact on clinical image quality and hence the deviations were considered unacceptable. The performance issues were addressed by the vendor through a hardware upgrade and optimisation of the energy window by increasing the lower discriminator value from 408.8 to 434.4 keV. Several repeat performance measurements taken from post-optimisation demonstrated improvement in peak NECR to 67 kcps with delayed window randoms subtraction "on" and 72 kcps with delayed window randoms subtraction "off". Scatter fraction taken from post upgrade and optimisation improved to an average of 33%, which is well within specification of <35%. All other performance tests (resolution, sensitivity, accuracy of corrections) were within specifications both prior and post-optimisation changes. This experience demonstrates the importance of equipment acceptance testing prior to clinical use so that deficiencies in performance can be addressed before the equipment is placed in clinical service.

The value of 18F‐FDG PET in pediatric patients with post‐transplant lymphoproliferative disorder at initial diagnosis

“…The PET images were reconstructed using the iterative method of line‐of‐response (line of response row action maximum‐likelihood algorithm or 3D row action maximum‐likelihood algorithm). The spatial resolution of the system was 5.1 mm in the transverse direction and 6.0 mm in the axial direction .…”

Response to chemotherapy in gastric adenocarcinoma with diffusion‐weighted MRI and 18F‐FDG‐PET/CT: Correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade

“…18 F‐FDG PET/CT studies were performed on four different PET‐CT scanner: “Discovery ST” , “Discovery STE” , Discovery‐690 (General Electric Medical Systems, GEMS, Milwaukee, WI) and “Gemini GXL” PET‐CT system (Philips Medical Systems, Best, The Netherlands) . PET/CT systems were cross‐calibrated with a dose measurement system.…”

A NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CT

“…The contrast recovery coefficient (CRC) is the percentage of measured net concentration normalized by the measured background concentration to true net concentration normalized by true background concentration. CRC provides information of how accurately the system reproduces the true activity concentration in a specific volume [ 14 ]. CRC for hot sphere j ( Q H,j ) was defined as follows [ 8 ]: …”